Compare AIMD & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIMD | GSIW |
|---|---|---|
| Founded | 1984 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 28.6M |
| IPO Year | N/A | 2023 |
| Metric | AIMD | GSIW |
|---|---|---|
| Price | $2.31 | $0.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 523.5K |
| Earning Date | 03-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $113,037.00 | ★ $8,087,497.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 178.19 | ★ 515.58 |
| 52 Week Low | $1.61 | $0.09 |
| 52 Week High | $4.50 | $1.79 |
| Indicator | AIMD | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 60.00 | 65.79 |
| Support Level | $1.70 | $0.14 |
| Resistance Level | $2.46 | $0.16 |
| Average True Range (ATR) | 0.18 | 0.01 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 80.92 | 96.24 |
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.